TG Therapeutics TGTX 深 沪
已收盘 12-19 16:00:00 美东时间
30.98
+1.050
+3.51%
华盛通- 最 高33.785
- 今 开29.96
- 成交量 149.32万股
- 最 低 29.50
- 昨 收 29.93
- 总市值 44.61亿
- 52周最高 46.48
- 市盈率 静 --
- 换手率 1.04%
- 52周最低 25.28
- 委 比 58.36%
- 总股本 1.44亿
- 历史最高 56.74
- 量 比 1.25
- 振 幅 14.32%
- 历史最低 0.9563
- 每 手 1
- 风险率 3.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
11-03 22:14
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
TG Therapeutics' CEO, Michael S. Weiss, will participate in the Jefferies Global Healthcare Conference in New York City on June 4, 2025, with a fireside chat at 12:50 PM ET. A live webcast will be available on the company’s website. TG Therapeutics is focused on developing treatments for B-cell diseases, including BRIUMVI, approved for treating multiple sclerosis. Contact details for investors and media are provided.
06-02 12:00
读懂IPO|必贝特市研率远高于5家同行，递表前估值猛涨10倍暗藏玄机
本文来源：时代商学院 作者：陈丽娜 来源|时代商业研究院 作者|陈丽娜 编辑|郑琳 核心产品未按既定日期获批上市，广州必贝特医药股份有限公司（下称“必贝特”）的估值或需重新审视。 必贝特是一家专注于创新药自主研发的企业，申请IPO后，于2023年6月1日向科创板提交注册，但截至目前仍未获得注册批文。2024年12月17日，其更换了会计师事务所并更新相关财务资料。 必贝特申请上市的标准较为特殊，由于其尚无商业化产品，且递表前持续亏损。因此，必贝特选择了对盈利能力要求较弱的科创板第五套上市标准，该标准的其中一条硬性指标为“预计市值不低于人民币40亿元”。 而凑巧的是，在递表前一年，必贝特通过数轮增...
02-21 20:30
Evaluating TG Therapeutics: Insights From 4 Financial Analysts
During the last three months, 4 analysts shared their evaluations of TG Therape...
2024-09-19 05:01
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $49 Price Target
HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $49 price target.
2024-09-19 01:02
What's Going On With ADMA Biologics Stock Monday?
ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.
2024-09-10 01:42
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nikola Corporation (NASDAQ:NKLA) fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a mixed shelf offering. Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in today’s mid-day session. G...
2024-08-20 01:37
